167 related articles for article (PubMed ID: 15857146)
1. C-5-disubstituted barbiturates as potential molecular probes for noninvasive matrix metalloproteinase imaging.
Breyholz HJ; Schäfers M; Wagner S; Höltke C; Faust A; Rabeneck H; Levkau B; Schober O; Kopka K
J Med Chem; 2005 May; 48(9):3400-9. PubMed ID: 15857146
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of a novel fluorescent photoprobe for imaging matrix metalloproteinases.
Faust A; Waschkau B; Waldeck J; Höltke C; Breyholz HJ; Wagner S; Kopka K; Heindel W; Schäfers M; Bremer C
Bioconjug Chem; 2008 May; 19(5):1001-8. PubMed ID: 18396900
[TBL] [Abstract][Full Text] [Related]
3. Radiofluorinated pyrimidine-2,4,6-triones as molecular probes for noninvasive MMP-targeted imaging.
Breyholz HJ; Wagner S; Faust A; Riemann B; Höltke C; Hermann S; Schober O; Schäfers M; Kopka K
ChemMedChem; 2010 May; 5(5):777-89. PubMed ID: 20373323
[TBL] [Abstract][Full Text] [Related]
4. A new generation of radiofluorinated pyrimidine-2,4,6-triones as MMP-targeted radiotracers for positron emission tomography.
Schrigten D; Breyholz HJ; Wagner S; Hermann S; Schober O; Schäfers M; Haufe G; Kopka K
J Med Chem; 2012 Jan; 55(1):223-32. PubMed ID: 22118188
[TBL] [Abstract][Full Text] [Related]
5. A 18F-radiolabeled analogue of CGS 27023A as a potential agent for assessment of matrix-metalloproteinase activity in vivo.
Breyholz HJ; Wagner S; Levkau B; Schober O; Schäfers M; Kopka K
Q J Nucl Med Mol Imaging; 2007 Mar; 51(1):24-32. PubMed ID: 17372570
[TBL] [Abstract][Full Text] [Related]
6. Novel fluorinated derivatives of the broad-spectrum MMP inhibitors N-hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](benzyl)- and (3-picolyl)-amino]-3-methyl-butanamide as potential tools for the molecular imaging of activated MMPs with PET.
Wagner S; Breyholz HJ; Law MP; Faust A; Höltke C; Schröer S; Haufe G; Levkau B; Schober O; Schäfers M; Kopka K
J Med Chem; 2007 Nov; 50(23):5752-64. PubMed ID: 17956082
[TBL] [Abstract][Full Text] [Related]
7. Pyrimidine-2,4,6-Triones: a new effective and selective class of matrix metalloproteinase inhibitors.
Grams F; Brandstetter H; D'Alò S; Geppert D; Krell HW; Leinert H; Livi V; Menta E; Oliva A; Zimmermann G; Gram F; Brandstetter H; D'Alò S; Geppert D; Krell HW; Leinert H; Livi VMenta E; Oliva A; Zimmermann G
Biol Chem; 2001 Aug; 382(8):1277-85. PubMed ID: 11592410
[TBL] [Abstract][Full Text] [Related]
8. A new class of highly potent matrix metalloproteinase inhibitors based on triazole-substituted hydroxamates: (radio)synthesis and in vitro and first in vivo evaluation.
Hugenberg V; Breyholz HJ; Riemann B; Hermann S; Schober O; Schäfers M; Gangadharmath U; Mocharla V; Kolb H; Walsh J; Zhang W; Kopka K; Wagner S
J Med Chem; 2012 May; 55(10):4714-27. PubMed ID: 22540974
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and preliminary biological evaluation of new radioiodinated MMP inhibitors for imaging MMP activity in vivo.
Kopka K; Breyholz HJ; Wagner S; Law MP; Riemann B; Schröer S; Trub M; Guilbert B; Levkau B; Schober O; Schäfers M
Nucl Med Biol; 2004 Feb; 31(2):257-67. PubMed ID: 15013492
[TBL] [Abstract][Full Text] [Related]
10. N-substituted homopiperazine barbiturates as gelatinase inhibitors.
Wang J; Medina C; Radomski MW; Gilmer JF
Bioorg Med Chem; 2011 Aug; 19(16):4985-99. PubMed ID: 21764590
[TBL] [Abstract][Full Text] [Related]
11. A dual inhibitor of matrix metalloproteinases and a disintegrin and metalloproteinases, [¹⁸F]FB-ML5, as a molecular probe for non-invasive MMP/ADAM-targeted imaging.
Matusiak N; Castelli R; Tuin AW; Overkleeft HS; Wisastra R; Dekker FJ; Prély LM; Bischoff R; van Waarde A; Dierckx RA; Elsinga PH
Bioorg Med Chem; 2015 Jan; 23(1):192-202. PubMed ID: 25438884
[TBL] [Abstract][Full Text] [Related]
12. Hydroxamate-based peptide inhibitors of matrix metalloprotease 2.
Jani M; Tordai H; Trexler M; Bányai L; Patthy L
Biochimie; 2005; 87(3-4):385-92. PubMed ID: 15781326
[TBL] [Abstract][Full Text] [Related]
13. Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.
Tauro M; Laghezza A; Loiodice F; Agamennone M; Campestre C; Tortorella P
Bioorg Med Chem; 2013 Nov; 21(21):6456-65. PubMed ID: 24071448
[TBL] [Abstract][Full Text] [Related]
14. Fluorinated matrix metalloproteinases inhibitors--Phosphonate based potential probes for positron emission tomography.
Beutel B; Daniliuc CG; Riemann B; Schäfers M; Haufe G
Bioorg Med Chem; 2016 Feb; 24(4):902-9. PubMed ID: 26810711
[TBL] [Abstract][Full Text] [Related]
15. A new development of matrix metalloproteinase inhibitors: twin hydroxamic acids as potent inhibitors of MMPs.
Rossello A; Nuti E; Catalani MP; Carelli P; Orlandini E; Rapposelli S; Tuccinardi T; Atkinson SJ; Murphy G; Balsamo A
Bioorg Med Chem Lett; 2005 May; 15(9):2311-4. PubMed ID: 15837315
[TBL] [Abstract][Full Text] [Related]
16. New beginnings for matrix metalloproteinase inhibitors: identification of high-affinity zinc-binding groups.
Puerta DT; Lewis JA; Cohen SM
J Am Chem Soc; 2004 Jul; 126(27):8388-9. PubMed ID: 15237990
[TBL] [Abstract][Full Text] [Related]
17. Optimizing the Biodistribution of Radiofluorinated Barbiturate Tracers for Matrix Metalloproteinase Imaging by Introduction of Fluorescent Dyes as Pharmacokinetic Modulators.
Schwegmann K; Hohn M; Hermann S; Schäfers M; Riemann B; Haufe G; Wagner S; Breyholz HJ
Bioconjug Chem; 2020 Apr; 31(4):1117-1132. PubMed ID: 32181649
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the pharmacology of hydroxamate- and carboxylate-based matrix metalloproteinase inhibitors (MMPIs) for the treatment of osteoarthritis.
Janusz MJ; Hookfin EB; Brown KK; Hsieh LC; Heitmeyer SA; Taiwo YO; Natchus MG; Pikul S; Almstead NG; De B; Peng SX; Baker TR; Patel V
Inflamm Res; 2006 Feb; 55(2):60-5. PubMed ID: 16612565
[TBL] [Abstract][Full Text] [Related]
19. Design and characterization of a metalloproteinase inhibitor-tethered resin for the detection of active MMPs in biological samples.
Hesek D; Toth M; Meroueh SO; Brown S; Zhao H; Sakr W; Fridman R; Mobashery S
Chem Biol; 2006 Apr; 13(4):379-86. PubMed ID: 16632250
[TBL] [Abstract][Full Text] [Related]
20. [Design, synthesis and activity evaluation of novel matrix metalloproteinases inhibitors based on the structure of enzyme].
Jia H; Guo YS; Ge YY; Wen H; Yang J; Yang XY; Du GH; Yang GZ
Yao Xue Xue Bao; 2007 Dec; 42(12):1271-81. PubMed ID: 18338640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]